Most women with rheumatic and musculoskeletal diseases will have successful pregnancies with the aid of medical planning, treatment and monitoring. These can be high risk pregnancies for both mother and child. The American College of Rheumatology recently issued treatment guidelines for the management of reproductive health in patients with rheumatic or musculoskeletal disease. Here are takeaways from the guidelines.
Pregnancy and Birth
Women with rheumatoid arthritis are concerned with pregnancy and parenting issues and require more information from their doctors, say researchers writing in ACR Open Rheumatology this month.
New recommendations cover pre-conception assessment, pregnancy-compatible medications, breastfeeding, and contraception for rheumatology patients.
Reassuring news for women with rheumatoid arthritis who need treatment with a TNF inhibitor during pregnancy.
New evidence is reassuring for women with rheumatoid arthritis who need treatment with a biologic throughout pregnancy.
In contradiction to long-standing beliefs, a healthy pregnancy is possible for women who have lupus, Dr. Jill Buyon says.
One in 50 women with lupus could have a child with neonatal lupus, but preventative steroid therapy may be unnecessary.
Tailored medication should be considered beyond conception to stabilize low disease activity and prevent flares during pregnancy, study reports.
RA patients with low disease activity in the first trimester of pregnancy, are likely to have low disease activity or reach remission by the third trimester.
The news from the PROMISSE study on pregnancy outcome in women with systemic lupus erythematosus is good for non-Hispanic white women and not so good for Hispanic white and African-American in women.